Deng L, Yao P, Li L, Ji F, Zhao S, Xu C, et al. p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival. Nat Commun. 2020;11:1755 pubmed publisher

Catizone A, Uzunbas G, Celadova P, Kuang S, Bose D, Sammons M. Locally acting transcription factors regulate p53-dependent cis-regulatory element activity. Nucleic Acids Res. 2020;48:4195-4213 pubmed publisher

Miyajima C, Kawarada Y, Inoue Y, Suzuki C, Mitamura K, Morishita D, et al. Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence. Cells. 2020;9: pubmed publisher

Srivatsan S, McFaline Figueroa J, Ramani V, Saunders L, Cao J, Packer J, et al. Massively multiplex chemical transcriptomics at single cell resolution. Science. 2019;: pubmed publisher

Adriaens C, Rambow F, Bervoets G, Silla T, Mito M, Chiba T, et al. The long noncoding RNA NEAT1_1 is seemingly dispensable for normal tissue homeostasis and cancer cell growth. RNA. 2019;25:1681-1695 pubmed publisher

Sun Q, Guo Y, Liu X, Czauderna F, Carr M, Zenke F, et al. Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814. Mol Cancer Res. 2019;17:2457-2468 pubmed publisher

Timofeev O, Klimovich B, Schneikert J, Wanzel M, Pavlakis E, Noll J, et al. Residual apoptotic activity of a tumorigenic p53 mutant improves cancer therapy responses. EMBO J. 2019;38:e102096 pubmed publisher

Han N, Moon P, Kim H, Jeong H. TSLP Exacerbates Septic Inflammation via Murine Double Minute 2 (MDM2) Signaling Pathway. J Clin Med. 2019;8: pubmed publisher

Besztercei B, Vancsik T, Benedek A, Major E, Thomas M, Schvarcz C, et al. Stress-Induced, p53-Mediated Tumor Growth Inhibition of Melanoma by Modulated Electrohyperthermia in Mouse Models without Major Immunogenic Effects. Int J Mol Sci. 2019;20: pubmed publisher

McKenzie M, Ghisi M, Oxley E, Ngo S, Cimmino L, Esnault C, et al. Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia. Cell Stem Cell. 2019;25:258-272.e9 pubmed publisher

Neitzel C, Seiwert N, Göder A, Diehl E, Weber C, Nagel G, et al. Lipoic Acid Synergizes with Antineoplastic Drugs in Colorectal Cancer by Targeting p53 for Proteasomal Degradation. Cells. 2019;8: pubmed publisher

Singh A, Bhattacharyya N, Srivastava A, Pruett N, Ripley R, Schrump D, et al. MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the MDM2-p53-Signaling Axis. Mol Ther. 2019;: pubmed publisher

Hsu C, Altschuler S, Wu L. Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy. Cell. 2019;: pubmed publisher

Zaman S, Yu X, Bencivenga A, Blanden A, Liu Y, Withers T, et al. Combinatorial therapy of Zinc metallochaperones with mutant p53 reactivation and diminished copper binding. Mol Cancer Ther. 2019;: pubmed publisher

Matson J, House A, Grant G, Wu H, Perez J, Cook J. Intrinsic checkpoint deficiency during cell cycle re-entry from quiescence. J Cell Biol. 2019;: pubmed publisher

Bowen M, McClendon J, Long H, Sorayya A, Van Nostrand J, Wysocka J, et al. The Spatiotemporal Pattern and Intensity of p53 Activation Dictates Phenotypic Diversity in p53-Driven Developmental Syndromes. Dev Cell. 2019;: pubmed publisher

Yang Y, Dong Z, Hu H, Peng J, Sheng Y, Tong Y, et al. The facile and visualizable identification of broad-spectrum inhibitors of MDM2/p53 using co-expressed protein complexes. Analyst. 2019;144:3773-3781 pubmed publisher

Deng H, Ikeda A, Cui H, Bartlett J, Suzuki M. MDM2-Mediated p21 Proteasomal Degradation Promotes Fluoride Toxicity in Ameloblasts. Cells. 2019;8: pubmed publisher

Wang C, Jiang S, Ke L, Zhang L, Li D, Liang J, et al. Genome-wide CRISPR-based gene knockout screens reveal cellular factors and pathways essential for nasopharyngeal carcinoma. J Biol Chem. 2019;294:9734-9745 pubmed publisher

Qin Y, Sekine I, Hanazono M, Morinaga T, Fan M, Takiguchi Y, et al. AMPK activation induced in pemetrexed-treated cells is associated with development of drug resistance independently of target enzyme expression. Mol Oncol. 2019;13:1419-1432 pubmed publisher

Saito Y, Muramatsu T, Kanai Y, Ojima H, Sukeda A, Hiraoka N, et al. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma. Cell Rep. 2019;27:1265-1276.e4 pubmed publisher

Zhou X, Li W, Wang S, Zhang P, Wang Q, Xiao J, et al. YAP Aggravates Inflammatory Bowel Disease by Regulating M1/M2 Macrophage Polarization and Gut Microbial Homeostasis. Cell Rep. 2019;27:1176-1189.e5 pubmed publisher

Ciardullo C, Aptullahoglu E, Woodhouse L, Lin W, Wallis J, Marr H, et al. Non-genotoxic MDM2 inhibition selectively induces pro-apoptotic p53 gene signature in chronic lymphocytic leukemia cells. Haematologica. 2019;: pubmed publisher

Gong H, An J, Dong Q, Li J, Yang W, Sun W, et al. Discovery of SCY45, a Natural Small-Molecule MDM2-p53 Interaction Inhibitor. Chem Biodivers. 2019;16:e1900081 pubmed publisher

Wang T, Li K, Song H, Xu D, Liao Y, Jing B, et al. p53 suppression is essential for oncogenic SPAG5 upregulation in lung adenocarcinoma. Biochem Biophys Res Commun. 2019;513:319-325 pubmed publisher

Xu X, Liu Q, Zhang C, Ren S, Xu L, Zhao Z, et al. Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence. Cell Death Dis. 2019;10:282 pubmed publisher

Khanal S, Galloway D. High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2. PLoS Pathog. 2019;15:e1007442 pubmed publisher

Zhong B, Shingyoji M, Hanazono M, Nguyễn T, Morinaga T, Tada Y, et al. A p53-stabilizing agent, CP-31398, induces p21 expression with increased G2/M phase through the YY1 transcription factor in esophageal carcinoma defective of the p53 pathway. Am J Cancer Res. 2019;9:79-93 pubmed

Fischer M. Conservation and divergence of the p53 gene regulatory network between mice and humans. Oncogene. 2019;38:4095-4109 pubmed publisher

Azatyan A, Gallo Oller G, Diao Y, Selivanova G, Johnsen J, Zaphiropoulos P. RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism. Cancer Lett. 2018;442:341-350 pubmed publisher

Nagaraja M, Tiwari N, Shetty S, Marudamuthu A, Fan L, Ostrom R, et al. p53 Expression in Lung Fibroblasts Is Linked to Mitigation of Fibrotic Lung Remodeling. Am J Pathol. 2018;188:2207-2222 pubmed publisher

Sriraman A, Dickmanns A, Najafova Z, Johnsen S, Dobbelstein M. CDK4 inhibition diminishes p53 activation by MDM2 antagonists. Cell Death Dis. 2018;9:918 pubmed publisher

Fedorova O, Daks A, Petrova V, Petukhov A, Lezina L, Shuvalov O, et al. Novel isatin-derived molecules activate p53 via interference with Mdm2 to promote apoptosis. Cell Cycle. 2018;17:1917-1930 pubmed publisher

Dijkstra K, Cattaneo C, Weeber F, Chalabi M, van de Haar J, Fanchi L, et al. Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids. Cell. 2018;174:1586-1598.e12 pubmed publisher

Senapati P, Dey S, Sudarshan D, Das S, Kumar M, Kaypee S, et al. Oncogene c-fos and mutant R175H p53 regulate expression of Nucleophosmin implicating cancer manifestation. FEBS J. 2018;285:3503-3524 pubmed publisher

Marcus J, Burke R, Doak A, Park S, Orth J. Loss of p53 expression in cancer cells alters cell cycle response after inhibition of exportin-1 but does not prevent cell death. Cell Cycle. 2018;17:1329-1344 pubmed publisher

Alessandrini F, Pezzè L, Menendez D, Resnick M, Ciribilli Y. ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells. Neoplasia. 2018;20:857-870 pubmed publisher

Li H, Gao Q, Shao Y, Sun B, Wang F, Qiao Y, et al. Gallid Herpesvirus 1 Initiates Apoptosis in Uninfected Cells through Paracrine Repression of p53. J Virol. 2018;92: pubmed publisher

Bellanne Chantelot C, Schmaltz Panneau B, Marty C, Fenneteau O, Callebaut I, Clauin S, et al. Mutations in SRP54 gene cause severe congenital neutropenia as well as Shwachman-Diamond-like syndrome. Blood. 2018;: pubmed publisher

Haapaniemi E, Botla S, Persson J, Schmierer B, Taipale J. CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. Nat Med. 2018;24:927-930 pubmed publisher

Charni Natan M, Solomon H, Molchadsky A, Jacob Berger A, Goldfinger N, Rotter V. Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner. Cell Death Dis. 2018;9:647 pubmed publisher

Bowling S, Di Gregorio A, Sancho M, Pozzi S, Aarts M, Signore M, et al. P53 and mTOR signalling determine fitness selection through cell competition during early mouse embryonic development. Nat Commun. 2018;9:1763 pubmed publisher

Machado D, Pizzorno A, Hoffmann J, Traversier A, Endtz H, Lina B, et al. Role of p53/NF-κB functional balance in respiratory syncytial virus-induced inflammation response. J Gen Virol. 2018;99:489-500 pubmed publisher

Consales C, Cirotti C, Filomeni G, Panatta M, Butera A, Merla C, et al. Fifty-Hertz Magnetic Field Affects the Epigenetic Modulation of the miR-34b/c in Neuronal Cells. Mol Neurobiol. 2018;55:5698-5714 pubmed publisher

Briest F, Grass I, Sedding D, Möbs M, Christen F, Benecke J, et al. Mechanisms of Targeting the MDM2-p53-FOXM1 Axis in Well-Differentiated Intestinal Neuroendocrine Tumors. Neuroendocrinology. 2018;107:1-23 pubmed publisher

Ullah K, Rosendahl A, Izzi V, Bergmann U, Pihlajaniemi T, Maki J, et al. Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways. Sci Rep. 2017;7:17220 pubmed publisher

Brown J, Yonekubo Y, Hanson N, Sastre Perona A, Basin A, Rytlewski J, et al. TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma. Cell Stem Cell. 2017;21:650-664.e8 pubmed publisher

Wiedenhoft H, Hayashi L, Coffin A. PI3K and Inhibitor of Apoptosis Proteins Modulate Gentamicin- Induced Hair Cell Death in the Zebrafish Lateral Line. Front Cell Neurosci. 2017;11:326 pubmed publisher

Moder M, Velimezi G, Owusu M, Mazouzi A, Wiedner M, Ferreira da Silva J, et al. Parallel genome-wide screens identify synthetic viable interactions between the BLM helicase complex and Fanconi anemia. Nat Commun. 2017;8:1238 pubmed publisher

Mazzucco A, Smogorzewska A, Kang C, Luo J, Schlabach M, Xu Q, et al. Genetic interrogation of replicative senescence uncovers a dual role for USP28 in coordinating the p53 and GATA4 branches of the senescence program. Genes Dev. 2017;31:1933-1938 pubmed publisher

Mattes K, Berger G, Geugien M, Vellenga E, Schepers H. CITED2 affects leukemic cell survival by interfering with p53 activation. Cell Death Dis. 2017;8:e3132 pubmed publisher

Mai W, Gosa L, Daniëls V, Ta L, Tsang J, Higgins B, et al. Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma. Nat Med. 2017;23:1342-1351 pubmed publisher

Lessel D, Wu D, Trujillo C, Ramezani T, Lessel I, Alwasiyah M, et al. Dysfunction of the MDM2/p53 axis is linked to premature aging. J Clin Invest. 2017;127:3598-3608 pubmed publisher

Mello S, Sinow C, Raj N, Mazur P, Bieging Rolett K, Broz D, et al. Neat1 is a p53-inducible lincRNA essential for transformation suppression. Genes Dev. 2017;31:1095-1108 pubmed publisher

Davaadelger B, Perez R, Zhou Y, Duan L, Gitelis S, Maki C. The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis. Cancer Biol Ther. 2017;18:895-903 pubmed publisher

Tang H, Lei C, Ye C, GAO P, Wan C, Chen S, et al. MDM2 is implicated in high-glucose-induced podocyte mitotic catastrophe via Notch1 signalling. J Cell Mol Med. 2017;21:3435-3444 pubmed publisher

Angius F, Piras E, Uda S, Madeddu C, Serpe R, Bigi R, et al. Antimicrobial sulfonamides clear latent Kaposi sarcoma herpesvirus infection and impair MDM2-p53 complex formation. J Antibiot (Tokyo). 2017;70:962-966 pubmed publisher

Urso L, Cavallari I, Silic Benussi M, Biasini L, Zago G, Calabrese F, et al. Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists. Oncotarget. 2017;8:44232-44241 pubmed publisher

Lee H, Wang H, Baladandayuthapani V, Lin H, He J, Jones R, et al. RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma. Br J Haematol. 2017;177:80-94 pubmed publisher

Corbel C, Sartini S, Levati E, Colas P, Maillet L, Couturier C, et al. Screening for Protein-Protein Interaction Inhibitors Using a Bioluminescence Resonance Energy Transfer (BRET)-Based Assay in Yeast. SLAS Discov. 2017;22:751-759 pubmed publisher

Soares J, Espadinha M, Raimundo L, Ramos H, Gomes A, Gomes S, et al. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties. Mol Oncol. 2017;11:612-627 pubmed publisher

Idogawa M, Ohashi T, Sasaki Y, Nakase H, Tokino T. Long non-coding RNA NEAT1 is a transcriptional target of p53 and modulates p53-induced transactivation and tumor-suppressor function. Int J Cancer. 2017;140:2785-2791 pubmed publisher

Ohashi T, Idogawa M, Sasaki Y, Tokino T. p53 mediates the suppression of cancer cell invasion by inducing LIMA1/EPLIN. Cancer Lett. 2017;390:58-66 pubmed publisher

Hideshima T, Cottini F, Nozawa Y, Seo H, Ohguchi H, Samur M, et al. p53-related protein kinase confers poor prognosis and represents a novel therapeutic target in multiple myeloma. Blood. 2017;129:1308-1319 pubmed publisher

Hölzer K, Drucker E, Roessler S, Dauch D, Heinzmann F, Waldburger N, et al. Proteomic Analysis Reveals GMP Synthetase as p53 Repression Target in Liver Cancer. Am J Pathol. 2017;187:228-235 pubmed publisher

Lee J, An S, Choi Y, Jung J, Li L, Meng H, et al. TRIAD1 Is a Novel Transcriptional Target of p53 and Regulates Nutlin-3a-Induced Cell Death. J Cell Biochem. 2017;118:1733-1740 pubmed publisher

Qian S, Li J, Hong M, Zhu Y, Zhao H, Xie Y, et al. TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia. J Hematol Oncol. 2016;9:128 pubmed

Zhao H, Shen R, Dong X, Shen Y. Murine Double Minute-2 Inhibition Attenuates Cardiac Dysfunction and Fibrosis by Modulating NF-?B Pathway After Experimental Myocardial Infarction. Inflammation. 2017;40:232-239 pubmed publisher

Prokesch A, Graef F, Madl T, Kahlhofer J, Heidenreich S, Schümann A, et al. Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis. FASEB J. 2017;31:732-742 pubmed publisher

Yue X, Zhao Y, Huang G, Li J, Zhu J, Feng Z, et al. A novel mutant p53 binding partner BAG5 stabilizes mutant p53 and promotes mutant p53 GOFs in tumorigenesis. Cell Discov. 2016;2:16039 pubmed

da Mota M, Cortez A, Benfica P, Rodrigues B, Castro T, Macedo L, et al. Induction of apoptosis in Ehrlich ascites tumour cells via p53 activation by a novel small-molecule MDM2 inhibitor - LQFM030. J Pharm Pharmacol. 2016;68:1143-59 pubmed publisher

Wen J, Lee J, Malhotra A, Nahta R, Arnold A, Buss M, et al. WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma. Oncogene. 2016;35:5552-5564 pubmed publisher

Yeo S, Itahana Y, Guo A, Han R, Iwamoto K, Nguyen H, et al. Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation. elife. 2016;5:e07101 pubmed publisher

Johmura Y, Sun J, Kitagawa K, Nakanishi K, Kuno T, Naiki Ito A, et al. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence. Nat Commun. 2016;7:10574 pubmed publisher

Korkmaz G, Lopes R, Ugalde A, Nevedomskaya E, Han R, Myacheva K, et al. Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9. Nat Biotechnol. 2016;34:192-8 pubmed publisher

Verhoef L, Mattioli M, Ricci F, Li Y, Wade M. Multiplex detection of protein-protein interactions using a next generation luciferase reporter. Biochim Biophys Acta. 2016;1863:284-92 pubmed publisher

Jiang H, Xu Z, Zhong P, Ren Y, Liang G, Schilling H, et al. Cell cycle and p53 gate the direct conversion of human fibroblasts to dopaminergic neurons. Nat Commun. 2015;6:10100 pubmed publisher

Aiken J, Roudier E, Ciccone J, Drouin G, Stromberg A, Vojnovic J, et al. Phosphorylation of murine double minute-2 on Ser166 is downstream of VEGF-A in exercised skeletal muscle and regulates primary endothelial cell migration and FoxO gene expression. FASEB J. 2016;30:1120-34 pubmed publisher

Tonsing Carter E, Bailey B, Saadatzadeh M, Ding J, Wang H, Sinn A, et al. Potentiation of Carboplatin-Mediated DNA Damage by the Mdm2 Modulator Nutlin-3a in a Humanized Orthotopic Breast-to-Lung Metastatic Model. Mol Cancer Ther. 2015;14:2850-63 pubmed publisher

Robert F, Barbeau M, Éthier S, Dostie J, Pelletier J. Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing. Genome Med. 2015;7:93 pubmed publisher

Li P, Zhao M, Parris A, Feng X, Yang X. p53 is required for metformin-induced growth inhibition, senescence and apoptosis in breast cancer cells. Biochem Biophys Res Commun. 2015;464:1267-74 pubmed publisher

Hünten S, Hermeking H. p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3. Oncotarget. 2015;6:15842-56 pubmed

Peng W, Hu C, Shu Z, Han T, Qin L, Zheng C. Antitumor activity of tatariside F isolated from roots of Fagopyrum tataricum (L.) Gaertn against H22 hepatocellular carcinoma via up-regulation of p53. Phytomedicine. 2015;22:730-6 pubmed publisher

Tebaldi T, Zaccara S, Alessandrini F, Bisio A, Ciribilli Y, Inga A. Whole-genome cartography of p53 response elements ranked on transactivation potential. BMC Genomics. 2015;16:464 pubmed publisher

Shai A, Dankort D, Juan J, Green S, McMahon M. TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis. Cancer Res. 2015;75:3167-80 pubmed publisher

Zajkowicz A, Gdowicz Kłosok A, Krześniak M, Ścieglińska D, Rusin M. Actinomycin D and nutlin-3a synergistically promote phosphorylation of p53 on serine 46 in cancer cell lines of different origin. Cell Signal. 2015;27:1677-87 pubmed publisher

Joshi Y, Sória M, Quadrato G, Inak G, Zhou L, Hervera A, et al. The MDM4/MDM2-p53-IGF1 axis controls axonal regeneration, sprouting and functional recovery after CNS injury. Brain. 2015;138:1843-62 pubmed publisher

Chen L, Rousseau R, Middleton S, Nichols G, Newell D, Lunec J, et al. Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma. Oncotarget. 2015;6:10207-21 pubmed

Soares J, Raimundo L, Pereira N, dos Santos D, Pérez M, Queiroz G, et al. A tryptophanol-derived oxazolopiperidone lactam is cytotoxic against tumors via inhibition of p53 interaction with murine double minute proteins. Pharmacol Res. 2015;95-96:42-52 pubmed publisher

Barabutis N, Dimitropoulou C, Birmpas C, Joshi A, Thangjam G, Catravas J. p53 protects against LPS-induced lung endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol. 2015;308:L776-87 pubmed publisher

Fraser J, Worrall E, Lin Y, Landré V, Pettersson S, Blackburn E, et al. Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis. J Mol Biol. 2015;427:1728-47 pubmed publisher

Overstreet J, Samarakoon R, Cardona Grau D, Goldschmeding R, Higgins P. Tumor suppressor ataxia telangiectasia mutated functions downstream of TGF-β1 in orchestrating profibrotic responses. FASEB J. 2015;29:1258-68 pubmed publisher

Wohak L, Krais A, Kucab J, Stertmann J, Øvrebø S, Seidel A, et al. Carcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism. Arch Toxicol. 2016;90:291-304 pubmed publisher

Ricci F, Subramanian A, Wade M. Open access to high-content clonogenic analysis. J Biomol Screen. 2015;20:391-401 pubmed publisher

Bethuyne J, De Gieter S, Zwaenepoel O, Garcia Pino A, Durinck K, Verhelle A, et al. A nanobody modulates the p53 transcriptional program without perturbing its functional architecture. Nucleic Acids Res. 2014;42:12928-38 pubmed publisher

Leão M, Gomes S, Bessa C, Soares J, Raimundo L, Monti P, et al. Studying p53 family proteins in yeast: induction of autophagic cell death and modulation by interactors and small molecules. Exp Cell Res. 2015;330:164-77 pubmed publisher

Das M, Duan W, Sahoo S. Multifunctional nanoparticle-EpCAM aptamer bioconjugates: a paradigm for targeted drug delivery and imaging in cancer therapy. Nanomedicine. 2015;11:379-89 pubmed publisher

Vandenberg C, Waring P, Strasser A, Cory S. Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained. Blood. 2014;124:1099-109 pubmed publisher

Zaccara S, Tebaldi T, Pederiva C, Ciribilli Y, Bisio A, Inga A. p53-directed translational control can shape and expand the universe of p53 target genes. Cell Death Differ. 2014;21:1522-34 pubmed publisher

Buss M, Remke M, Lee J, Gandhi K, Schniederjan M, Kool M, et al. The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants. Oncogene. 2015;34:1126-40 pubmed publisher